Aptar launches new inhaler with eye on emerging markets
Just in time for World Asthma Day, Aptar Pharma is launching a capsule-based dry powder inhaler.
TOP HEADLINES
Top Story
Researchers develop 'smart' nanostructures for drug delivery
Scientists at Johns Hopkins and Brown are developing self-assembling nanostructures that can break apart on their own to deliver drugs.
Liquidia touts promise of next-gen respiratory delivery
Liquidia Technologies' PRINT platform is a particle-engineering technology that has performed well in two recent studies.
MIT: Staggering cancer drugs can make them more effective
Researchers have come up with a method of staggering doses that has led to increased effectiveness of cancer drugs.
UNC researchers craft siRNA platform that can switch its solubility
Scientists at UNC have come up with a drug carrier that holds together in the blood stream and then dissolves once it reaches its target cells.
DNA origami could allow for 'autonomous' delivery
Researchers at Harvard's Wyss Institute are using the method to develop self-assembling, self-destructing drug delivery vessels.
Japanese firm buys Altea's assets, plans to launch transdermal tech
Nitto Denko has acquired all of Altea's assets, planning to use the company's transdermal technology to launch a patch on its own.
From Our Sister Sites
Almost two years after receiving an FDA warning letter citing 9 violations at its Everett, WA, laboratory, SNBL USA announced that it remedied 7 of them. But while the U.S. subsidiary of Japanese CRO Shin Nippon Biomedical Laboratories is resolving its issues in one part of the world, it is caught up in an animal rights scandal in another.
The Indiana CRO will have to reconfigure some of its lab operations in an effort to recoup losses, according to its second-quarter report.
POPULAR COMMENT THREADS